2020. Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s94. DOI:https://doi.org/10.25251/skin.4.supp.94.